Tamboran Resources (ASX:TBN) completed the acquisition of Falcon Oil & Gas through the acquisition of its subsidiaries after the receipt of final approval from the Supreme Court of British Columbia, according to a Friday filing with the Australian bourse.
The company now holds roughly 2.8 million net prospective acres, the filing said.
The company issued about 6.5 million shares of common stock to eligible Falcon shareholders on completion of the transaction, per the filing.
Toyota Motor (TYO:7203) will halt development of a mass-production version of the Lexus LF-ZC sedan, a next-generation electric vehicle originally intended to utilize advanced gigacasting technology, Nikkei Asia reported on Friday.The automaker is pivoting toward SUVs and other models as EV sales slow worldwide, with production initially scheduled for late this year but then delayed to mid-2027 at a plant in Aichi Prefecture, the news agency said.Despite Toyota's global EV sales rising 42% in 2025 to over 190,000 units-boosted by the revamped bZ4X SUV and the China-only bZ3X-the broader market now faces significant challenges, the publication said.These include the Trump administration's removal of EV purchase tax incentives and the European Union's reversal of its planned 2035 ban on new internal combustion engine vehicles, the report said.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Cynata Therapeutics (ASX:CYP) said the World Health Organization (WHO) selected pixenstrocel as the proposed generic name for Cymerus induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells (MSC), according to a Friday Australian bourse filing.The proposed generic name is expected to be published in 2027 in the WHO Drug Information List 136 of Proposed International Nonproprietary Name, the company said. The final confirmation is expected around May 2027.The generic name represents the active agent in iPSC-derived MSC products.
Standard Chartered (HKG:2888) plans to issue $1.00 billion in bonds, according to a Friday filing with the Hong Kong bourse.The lender plans to issue the debt in the form of fixed-rate resetting perpetual subordinated contingent convertible securities that will be listed in London and Hong Kong. Issuance is expected to take place June 8.The bonds will offer interest at an initial rate of 7% and convert into shares of Standard Chartered at the rate of $26.379 per share.Funds raised will be used for general business purposes, the bank said.